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Using h i rud in  as a mode l  a novel c lass o f  bivalent th rombin  inhibi tors has been designed and characterized (Maraganore  t al. (1990) Biochemistry 
29, 7095-7101). These peptides, designated "hirulogs',  interact with both  thrombin 's  catalytic center and its an ion-b ind ing exosite for f ibr inogen 
recognit ion.  In order  to investigate st ructure ac: ivity re lat ionships in h i ru log peptides, a number  o f  peptide and pept idomimet ic  derivatives with 
a l terat ions in catalytic-site b inding and an ion-b ind ing exosite b inding moieties were prepared.  Replacements  or  modif icat ions in the catalytic site 
and  exosite b ind ing moieties were achieved witl~ the consequences o f maint~imng or  improv ing  ant i th rombin  activity. In addit ion to showing 
improved affinity for th rombin ,  some derivatives with g,'s in the sub-nanomolar  range showed increased ant icoagulant  activities. These findings 
highl ight the versatil ity o f  h i ru log peptides in their bivalent interactions with thrombin .  
Thrombin :  Inhibitor= Hirulog: H i rud in  
I. INTRODUCTION 
H i rud in ,  a 65-amino  ac id  prote i l t  o=ig ina l ly  i so la ted  
f rom the  med ic ina l  leech  Hirudo medicinalis, is a potent  
natura l  inh ib i to r  of" th rombin  [1,2]. K inet i c  ana lys i s  o f  
the  inh ib i t ion  o f  th rombin  by  h i rud in  [3] revea led  two 
s teps  in s to ich iometr i c  complex  fo rmat ion :  f irst,  e lec -  
t ros ta t i c  in teract ions  at  the  an ion-b ind ing  exo~i te  for  
f ib r inogen recogn i t ion  [4], and  second,  in teract ions  at  
the  enzyme cata ly t i c  center .  X - ray  c rys ta l lograph ic  
ana lys i s  o f  the  h i rud in : thrombin  complex  [5] showed 
that  the  h igh  af f in i ty  in teract ion  (K, --- 10 -~- i0  -~4 M)  is 
ach ieved  by  212  contacts  o f  < 4 A, across  the ful l  dia~.t -
e ter  o f  the  thrombin  molecu le .  
The  interat:t lOnS o f  th rombin  w i th  h i rud in  have  
served  as  a mode l  fo r  the  des ign  o f  new pept ide  mhi -  
b i to rs  des ignated  "hiru logs'  [6]. As  w i th  h i rud in ,  h i ru log  
pept ides  b ind  to  th rombin  in a b iva lcn~ fash ion  in teract -  
ing  w i th  both  the  cata ly t i c  s i te  and  the  anion-~-ir ,  d ing  
exos i te .  However ,  in the  case  o f  h i -u log  pept idcs ,  b i -  
va lent  in teract ions  are ach ieved  by  a shor t  l inker  zeg-  
ment  compr ised  o f  g lyc inc  res idues  whose  length  was  
optimizer~_ ",o b [ idge  tnc in teratomic  d i s tance  between 
the  t ,vo  thrombin  funct iona l  s i tes.  As  a resu l t  o f  these  
in teract ions ,  h J ru log  pept ides  inh ib i t  th rombin  ac t iv i t ies  
w i th  Kt va lues  in the  low nM range.  
In  th,  ~ in i t ia l  des ign  o f  h i ru log  pept ides  [6], the  se-  
quence  D-Phe-Pro -Arg  [7,8] was  employed as  the  act ive  
s i te - inh ib i to ry  moiety  and  a segment  homologous  to  
res idues  53-454 o f  the  HV2 h i rud in  var iant  [9] was  
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fo r  b ind ing  to  the an ion-b ind ing  exositc ' .  In the present  
repor t ,  we  have  examined the use  o f  a~.d i t iona l  pept ide  
and  non-pept ide  subst i tuents  capab le  o f  fu l f i l l ing s imi -  
lar  cognate ,  b iva lent  in teract ions  w i th  thrombin .  
2. MATERIALS  AND METHODS 
2.1. Materials 
t-Boo amino  acids for sol id-phase peptide synthesis ,~rere f rom 
~2hernical Dynamics  Corp. ,  South  Plainfield, NJ .  Protected amino  
a,:ids f rom this suppl ier  were: Boc-O-(2-bromo-CBZ)-L- tyros ine,  Boc- 
L-g lutamic acid y-benzyl ester. Boc-L-aspart ic  a¢id~*bcnzyl ester, and 
Boc-O-benzyl-L-ser ine.  Bo¢-L- leu¢ine-O-divinylbenzene resin was 
f rom Applieti B iosystems Inc., Foster  City, CA.  Boc-L-g lutamine-O-  
divinylbenzene, and Boc, y.benzyI-D.glutamate-O~divinylbenzene 
• "~ins were purchased f rom Peninsula Laborator ies .  Belmont,  CA. 
F rom Bachem Inc., Torrance,  CA,  were Boc-glycy|glycine and Boc- 
cyclohexyI-L-alanine_ para-Guanidinobenzoic acid was purchased 
from Fhka  Chemical  Corp. ,  Ronkonkoma,  NY.  Spectrozyme TH 
(H-D-hexah~,drutyrosyI -L-a lanine-L-arginine-p-nitroani l ide)  was  ob- 
tained f rom Ame=ican Diagno~lica, New York ,  NY.  Human a- 
th rombin  was the generous  gift o f  Dr. John  W. Fenton,  I1, Wadswor th  
Center  for  Laborator ies  and Research,  New Y¢,,~, State Depar tment  
of  Health,  A lbany,  NY.  HPLC solvents were f rom Baker. Reagents 
and solvents employed in peptide synthesis were from. Appl ied Bin- 
systems Inc., Fos ter  City, CA.  
2.2. P~'ptide synthesi.¢ 
H;ru log pept ides were synthesized by sol id-phase procedures,  
cleaved and extracted f rom resin, and purified by reverse-phase HPLC 
as described previously  [6]. The  structure o f  pept ides wa', conf irmed 
by amino  acid analysis. Hirulog-tz2 was  prepared by react;.on o f  p-  
guanid inobenzo ic  a id (4.63 retool) with 0.46 g o f  the protected, resit~- 
bound intermediate o f  the heptadecape2alide (G)  sNGDFEEIPEEYL .  
The  structure o f  h;.nllog-Ot2 was  conf i rmed by FAIBbMS showing  a 
Mf l - I  + = 1901.0 (theoretical mass  = |899).  
2.3. Tyrosine modification o f  hirulog- I
Tyrosine-19 of  hiruiog- I  was  sulfated by a modif icat ion [10] o f  the 
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method of  Nakahara  ct al, {I I]. Sulfated hirulog-i  was purified by 
reverse-phase HPLC using an Applied Bit, systems 150A Liquid Chro- 
matographic system equipped with an Aquapore C, R.P-~Lu~ colunm 
{0.d6 × 100 ram). The column was equil ibrated in 100% solvent A 
(0. I ~ TFA/water)  a' ld developed with a l inear gradient from 0 to 50% 
solvent B (0.085% "! FA/70C~ acetonitri le) over 4~ rain a~ a flow-rate 
of  1~0 ml/min. The effluent stream was monitored at 214 nm for 
absorbance and pea. :s were collected manually.  The yield for tyrosine 
sulfation of  hirulog- I was ~10%. 
Diic, do-birulog-I  was prepared by standard tyrosine iodinat~on 
methods using chlo:ainine T. The peptide was purified by HPLC on 
an octasilyl co lumn (Aquapore RP-300, 0.46 x i00 ram) equi l ibrated 
with 20% solvent B and developed with a l inear gradient f rom 20 to 
65% solvent B over 30 rain at a flow-rate of  1.0 ml/min. The effluent 
stream was monitored at 214 am. Peaks of  UV absorbance were 
collec:ed manual ly and. then. lyophilizcd to dryness. 
2,4. Kinet ic studies 
Inhibit ion by hirulog peptideg of  thrombin  amidolytic activity was 
performed as reported earlier [6]. Assays were performed using a 0.05 
M sodium borate, pH 8.4, buffer ~:ontaining 0.I M NaCI at a tempera- 
ture of 23-25°C. Reactions were initiated by addit ion of substrate to 
the cuvette containing thrombin and inhibitor pre-mixed for less than 
2 rain. 
2.5. Clott ing assays 
The ant icoagulant activity of hirulog peptides was measured semi- 
automatical ly as reported earlier [6]. Final concentrat ions of hirulog 
peptides or rec-hirudin (American Diagnostica, New York, NY)  were 
1.0/z~ml.  Each assay was performed in triplicate. 
3. RESULTS AND DISCUSSION 
In  o rder  to  exp lore  the  versa l i ty  o f  b iva lent  in terac -  
t ions  between h i ru log  and  thrombin ,  we  eva luated  the  
ant i th rombin  ac t iv i t i~  o f  severa l  nove l  der ivat ives .  
These  der i :~: . :ves  were  des igned w i th  un ique  domains  
fo r  b ind in~ to  e i ther  the  ac t ive  center  (h i ru logs -oex)  o r  
the  thrombin  exos i te  (h i ru logs - /~x) .  In  add i t ion ,  as  ty -  
ros ine  su l fa t ion  was  repor ted  prev ious ly  to  s ign i f i cant ly  
enhance  the  - r~ icoagu lant  ac t iv i ty  in  the  C - termina l  
_Deptide h~tuget  ~i0],  x¢e examined the  consequence  o f  
ty ros ine  su l fa t i ,~n  and  iod inat ion  in  h i ru log - l .  Tab le  ! 
p reset , i s  a L~t ol  pept ides  prepared  fo r  th i s  s tudy ,  as  we l l  
as  the i r  des ignat ion  and  amino  ac id  sequences .  
H i ru log- I  inh ib i ted  thrombin -cata lyzed  hydro lys i s  o f  
~- ~r i i~p!~dy l  chromogen ic  subst r~te  w i th  g i  = 1.4 nM 
in  a compet i t i ve  fash ion .  As  observed  w i th  C - termina l  
h i rud in  f ragments ,  su i fa t ion  o f  ty ros ine -  19 (cor respond-  
ing  to  Tyr -63  in  h i rud in )  led  to  a s ign i f i cant  inc rease  in  
ac t iv i ty  (Tab le  I).  Su l fa ted  h i ru log- I  (S -h i ru log- l )  in -  
h ib i ted  the  thrombin -cata lyzed  hydro lys i s  o f  the  t r ipep-  
udy l  subst ra te  w i th  3-  to  4 - fo ld  (K i  = 0 .4  nM)  greater  
e f fec t iveness  over  the  unsu l fa ted  der ivat ive .  The  ga in  in  
f ree  energy  o f  b ind ing  der ived  f rom th is  s ing le  mod i f i ca -  
t ion  was  3.1 kJ/~z~o! (F ig .  i ) ,  wh ich  is somewhat  less  
than  the  -6  k J / too l  change in  f ree  energy  o f  b ind ing  
resu l t ing  f rom tyros inc  su i fa t ion  in  h i rud in  [12] .  
Never the less ,  th i s  f ind ing  showed that  the  ac t iv i ty  o f  
h i ru log  pept ides  can  be  enhanced by  increas ing  the i r  
a f f in i ty  fo r  an ion-b ind ing  exos i te  in teract ions .  Together  
w i th  increased  thrombin  a f f in i ty ,  su l fa ted  h i ru log- I  
showed a modest ly  inc reased  ant icoagu lant  ac t iv i ty  in  
c lo t t ing  t ime assays  (F ig .  2 )  as  compared  to  h i ru log - l .  
As  found recent ly  in  the  X - ray  c rys ta l lograph ic  s t ruc -  
tu re  o f  the  h i rugen- thrombin  complex  [13] ,  ty ros ine  
su i fa t ion  . i~tcrea~e:s the  b ind ing  a f f in i ty  fo r  complex  
fo rmat ion  v ia  par t i c ipat ion  o f  the  su l fa te  group  in  an  
e laborate  hydrogen-bond ing  network  inc lud ing  the  phe-  
no l i c  OH o f  Tyr -76  and  the  backbone amide  o f  I1e-82.  
D i iod inat ion  o f ty ros ine  reduces  the  pK  fo r  i t s  hydroxy l  
g roup ,  a l low ing  the  der ivat i zed  amino  ac id  to  par t i -  
c ipate  as  a hydrogen-bond agx~eptor  in  the  thrombin  
complex  a t  neut ra l  pH.  To  determine  i f  Tyr  iod~nat ion  
cou ld  improve  the  potency  o f  h i ru log  pept ides  in  a 
manner  s imi la r  to  Tyr  su l fa t ion ,  the  d i iodo-Tyr -19  de-  
r ivat ive  o f  b i ru log - !  was  prepared .  In  chromogen ic  sub-  
s t ra te  assays ,  d i iodo-h i ru log- I  showed a K~ = 0 .3  nM,  
i .e. a s imi la r  inc rease  in  ant i th rombin  ac t iv i ty  as  ob-  
served  w i th  ty ros ine  su l fa t ion .  
In teract ions  a t  the  an ion-b ind ing  exos i te  were  a l so  
mod i f ied  by  employ ing  d ivergent  sequences  f rom two 
h i rud in - rc la ted  i so forms,  h i ru l l in  [14]  and  h i rud in  PA  
[15],  as  we l l  as  a h igher  a f f in i ty  f ragment  des igned by  
Krs tenansky  and  co -workers  [16]  ca l led  MDL-28 ,059.  
As  Tab le  I shows ,  these  exos i te  recogn i t ion  f ragments  
cou ld  be  in tegrated  w i th in  the  f ramework  o f  a h i ru log  
pept ide  to  mainta in  inh ib i to ry  ac t iv i t ies  toward  
thrombin  hydro lys i s  o f  a t r ipept idy l  subst ra te .  Of  these  
Table I 
Deslgnatior, and amino acid sequences of  hirulog t~eptides, and kinetic constants for human ct-thlombin inhibit ion 
Peptide Sequence: K, (riM) 
Hirulog- I
S-Hirulog- I
dl-Hivalog-! 
Hirulog-~ I 
Hirulog-~2 
Hirulog-~l  
Hiru|og-)$2 
Hirulog-,03 
(D- Phe)Pro A rgP ro(G ly)4Asn(~;I yAspPheG|uGlu  | leProC;luGI uTyrLeu 1.4 
(D-Phe)ProArgPro(G ly )~snGlyAspPheG|uGlu l  leProGluGlu(SO~-Tyr)Leu 0.4 
(D- Phe)ProArRPro(G ly )~snGlyA~pPh~luGlu l leProGluGlu(12-Tyr )Leu  0.3 
acGlyAspPhe LeuAlaGluGI  yGlyGlyValArgPro(G ly )4AsnGtyAspPhe~GluGlui leProGluGluTyrLeu 3.2 
GBA(G ly)5 AsnGlyAspPheGluGlu l leProGluGI  uTyrLe u 7000 
(D-Phe)ProArgPro(Gly)4AspGlyAspPhcGluGluSerLeuAspAspl  leAspGln I. 1 
( D-Phe)ProArgPro{Giy)4AspGiyAspPheGluProI leProGluGI  uTyrLeuGIn 5.4 
( D -Phe)ProArgProgGly )~spG|yAspTyrG luPro l  leProG luCih-~ -Cha(D-Glu)  0.3 
K, values were determined as reported in section 2. Assays were performed at 23-25°C with a 0.05 M ~,~dium borute, pH 8.4, buffer conta in ing 
0. |  M NaCI. 
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F ig .  i .  B ind ing  energy  decrease  for  h i ru log  pept ides  as  compared  w i th  
h i ru log - l .  The inh ib i to ry  act iv i t ies  o f  h i ru log  pept ides  toward  throm-  
b in -cata lyzed  hydro lys i s  o f  chromogen ic  suhst ra tes  were measured  as 
descr ibed  in sect ion  2 and  prev ious ly  [6]. F ree  energy  o f  b ind ing  va lues  
were ca lcu la ted  us ing  the determined  K, va lues  for  th rombin  in amido-  
lyt ic  assays.  
new h i ru log  der ivat ives ,  h i ru log- f l3  showed the greatest  
improvement  in ac t iv i ty  (K  i =- 0.3 nM) ,  a f ind ing con-  
s istent  with its enhanced exos i te  af f in i ty.  As  wi th  ty-  
ros ine su l fa t ion  in h t ru log- l ,  the increased  act iv i ty  o f  
h i ru log-~3 was  a l so  observed  in coagu la t ion  assays  
(F ig .  2). However ,  whi le  su l fa ted  h i ru log- l  a i id h i ru log-  
,03 showed s imi la r  K i ' s  for  th rombin  in amido ly t i c  as-  
says,  the l~tter  was  unexpectant ly  more  ef fect ive in c lot -  
t ing  t ime assays .  A t  ! .0/ug/mi,  h i ru log- f l3  p ro longed the 
APTT  to  498% cont ro l ,  an  effect wh ich  exceeded s igni f -  
i cant ly  that  for  h i ru log- l ,  su l fa ted  h i ru log- l ,  and  rec- 
h i rud in .  A d i scont inu i ty  between ant i th rombin  and  
ant icoagu lant  act iv i t ies  had  been observed  prev ious ly  
for  o ther  h i ru log  der ivat ives  [! 7]. 
H i ru log  pcpt ides  descr ibed  prev ious ly  [6] employed 
the sequence  D-Phe-Pto -Arg -Pro  as  the act ive s i te -b ind-  
ing n~oiety. In the present  study~ we found that  the 
funct ion  o f  th is  mo ie ty  can  be ach ieved  w i th  a d ivergent  
pept ide  sequence  or ,  in fact,  a non-pcpt id ic  subst i tu t ion .  
The  f ib r ipopept ide  A (FPA)  f ragment  ar ises f rom 
thrombin 's  c leavage o f  the Ant-chain o f  f ib r inogen,  and  
is known to  b ind  near  o r  at  the act ive  center  o f  th rombin  
[18]. A segment  o f  FPA  cor respond ing  to  res idues  6 -16  
was  used to  rep lace  the sequence  D-Phe-Pro -Arg  in the 
synthes is  o f  h irulog-nt 1. As  wi th  h i ru log-  I, the nt I der iv -  
at ive  inh ib i ted  thrombin -cata lyzed  hydro lys i s  o f  a chro -  
mogen ic  subst ra te  wi th  a Ki in the low nM range  (Tab le  
1). The  s imi lar i t ies  in th rombin  inh ib i t ion  by h i ru log- I  
and  -~!  wou ld  ind icate  that  the  D-Phc -Pro -Arg  t r ipep-  
t ide and  the FPA undeca l~pt ide  themse lves  bi~ad to  the  
act ive  center  w i th  comparab le  af f in i ty  and ,  perhaps ,  
s imi la r  loci. 
S ince h igh ly  d ivergent  sequences  cou ld  be used as 
act ive  s i te -b ind ing  moiet ies  in h i ru log  pept ides ,  the pos -  
s ib i l i ty  o f  rep lac ing  th is  segment  w i th  a non-pept id ic  
subst i tuent  was  considerecl  in des ign  o f  hirulog-cz2. The  
pept idomimet ic  funct ion  employed was  p -guan id ino -  
benzo ic  ac id  (GBA) .  based  on  the observat ions  that  
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Fig. 2. Anticoagulant activities of rec-hirudin and hirulog 10~ptides. All 
assays  were pcr fo rm~l  with poo led,  normal  human p lasma wi th  roe- 
h i rud in  or  h i ru log  pept tde  concent ra t ions  o f  1.0 ~ug/ml. Data  arc  ex- 
pressed as n~ean (SEM < 10%). 
benzamid ine  and  benzamid ine- re la ted  compounds  can 
inh ib i t  th rombin  amido ly t i¢  act iv i ty  by b ind ing  to  the 
S t o r  "pr imary" speci f ic i ty pocket  [19]. Fur ther ,  by  ana l -  
ogy  with the s t ructure  o f  the thrombin  complex  with 
O-Phe-Pro -Arg -CH2C!  [20], the ( JBA  funct iona l i ty  
wou ld  be expected  to occupy  the pos i t ion  o f  the Pt 
(nomenc la ture  o f  Schechter  and  Burger [21]) a rg in ine  
s ide cha in  in the S~ pocket .  Us ing  carbod i imide  chemis -  
try,  GBA was coup led  in essent ia l ly  s to ich iometr i c  y ie ld 
to  the res in -bound,  p ro tected  in termed iate  o f  a hepta -  
decapgpt ide  (G lys -Asn-G ly -Asp-Phe-G lu -G lu - I le -P ro -  
G lu -G lu -Tyr -Leu) .  The  resu l t ing  GBA-pept ide  inhi-  
b i ted  thrombin  hydro lys i s  e ra  t r ipept idy l  subst ra te  with 
Ki = 7 MM. In cont ras t ,  the unmodi f ied  heptadecapep-  
t ide d id  not  inh ib i t  th rombin  amido ly t i c  act iv i ty  at  con-  
cent ra t ions  exceed ing  50 /zM [6]. Thus,  h i ru log-r -2 
mainta ins  b iva lent  in teract ions  with thrombin  ae with 
o ther  h i ra log  pept ides ,  but  wi th  act ive site in teract ions  
l imi ted  to  the S, pocket .  The  aff in i ty o f  hirulog-nt2 for 
act ive site inh ib i t ion  d i f fered substant ia l l y  f rom that  o f  
h i ru log-  1. where  a loss in b ind ing  energy o f  2 !. 1 k J / reel  
was observed  (F ig .  I). Th is  reduced af f in i ty can F~e ex- 
p la ined ,  i f  not  ant i c ipated ,  by the absence, o f  in teract ions  
at Pz and  P3 sites in the act ive  center  o f  th rombin .  
The  present  f ind ings h igh l ight  the versat i l i ty  o f  hi- 
ru log  pept ide  in teract ions  with thrombin .  A number  o f  
d ivergent  sequences  can be employed for b ind ing  to  the 
an ion-b ind ing  exos i te ,  inc lud ing  those  der ived  f rom hi- 
rud in  ~soforms. In teract ions  at  the act ive site can be 
ach ieved  us ing  both  pept id ic  and  non-pept id ic  funct io -  
nal i t ies.  By increas ing  the af f in i ty for an ion-b ind ing  ex- 
os i te  in teract ions ,  the ant i r th rombin  and  ant icoagu lant  
act iv i t ies  o f  h i ru log  can  be improved.  These  stud ies  
show that  a wide range  o f  pept ide  and  non-pept ide  
moiet ies  can  fulfil l b iva lent  th rombin  in teract ions  in 
h i ru log  pept ides .  
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